Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
Saved in:
Main Authors: | Marco Rossato, Angelo Di Vincenzo |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/3fae216483b24c21bb8e521c10d63e6f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
by: Maki Komiyama, et al.
Published: (2020) -
The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
by: Osama A. Amin, et al.
Published: (2021) -
Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
by: Bin Tu, et al.
Published: (2021) -
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
by: Maki Komiyama, et al.
Published: (2020) -
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
by: Eliecer Coto, et al.
Published: (2021)